A Study of LY4100511 (DC-853) in Adult Participants With Moderate-to-Severe Plaque Psoriasis
Phase
2Span
45 weeksSponsor
DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and CompanyTakaoka, Toyama
Recruiting
1-1 of 1